AspDH-Engineered E. Coli Fermentation for Higher Vitamin B5 Yield
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The chemical synthesis of vitamin B5 (VB5) is highly polluting, producing toxic waste that is difficult to treat, leading to environmental concerns and supply shortages, while microbial fermentation methods have low yields and require excessive β-alanine addition.
Innovation Solution
Overexpressing the aspartate dehydrogenase gene (aspDH) from Delftia sp. Csl-4 in E. coli, combined with other enzymes, to enhance the production of VB5, using a combination of enzymes such as PgapA and RBS, and incorporating the panBCE, and incorporating the panB, panC, and panE genes to improve the fermentation yield.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If chemical synthesis method is used to produce VB5, then production efficiency is high, but environmental pollution is severe and waste treatment is difficult
Solution Approach 1:
The patent replaces the chemical synthesis system with a biological fermentation system. Specifically, it uses engineered E. coli bacteria with enhanced aspartate dehydrogenase activity to catalyze the conversion of aspartic acid to β-alanine and subsequently to VB5, substituting chemical reagents and processes with enzymatic pathways that are inherently more environmentally benign.
Solution Approach 2:
The patent changes the fundamental production parameter from chemical synthesis to microbial fermentation. By optimizing bacterial strain characteristics, fermentation conditions, and metabolic pathway expression, it achieves high productivity through biological means while eliminating the harmful chemical waste associated with traditional synthesis methods.
2Object-generated harmful factors
If microbial fermentation method is used to produce VB5, then environmental pollution is reduced, but fermentation yield is extremely low
Solution Approach 1:
The patent performs preliminary genetic engineering of the E. coli strain before fermentation to enhance its VB5 production capability. It overexpresses aspartate dehydrogenase genes and optimizes the metabolic pathway in advance, so that during fermentation the bacteria naturally produce high yields of VB5 without requiring excessive external β-alanine supplementation.
Solution Approach 2:
The engineered bacteria serve themselves by autonomously producing the necessary enzymes and metabolic intermediates for VB5 synthesis. The enhanced aspartate dehydrogenase activity enables the bacteria to efficiently convert aspartic acid to β-alanine internally, eliminating the need for external supplementation and achieving high yields through self-sustained metabolic pathways.
3Productivity
If excessive β-alanine is added to fermentation medium to increase VB5 yield, then fermentation yield improves, but production cost increases and process complexity increases
Solution Approach 1:
The bacteria are genetically engineered to produce β-alanine endogenously through enhanced aspartate dehydrogenase activity. This self-service capability eliminates the need for external β-alanine supplementation, simplifying the fermentation process while maintaining high VB5 yields.
Solution Approach 2:
The patent extracts the β-alanine production step from the external medium supplementation approach and relocates it to the internal bacterial metabolic pathway. By enhancing the aspartate dehydrogenase enzyme within the bacteria, the system generates β-alanine in situ, removing the complexity of external addition and monitoring.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enhances the fermentation yield of VB5, utilizing renewable raw materials and facilitating easy treatment of waste residues, thereby reducing pollution and increasing supply.
Implementation Method 1
aspartate dehydrogenase encoded by an aspDH gene catalyzes the synthesis of aspartic acid from oxaloacetate and ammonium
Implementation Method 2
The microbial fermentation method for VB5 production not only use renewable glucose as a raw material
Data Source
AI summary
The present application relates to the field of microorganisms, and specifically relates to Escherichia coli expressing aspartate dehydrogenase aspDH and a method for producing vitamin B5 by fermentation. Overexpression of the aspDH gene shows the best result by comparing the fermentation yield of VB5. Compared with the highly polluting chemical method for the production of vitamin B5, the biological method for the production of vitamin B5 of the present application has the advantages of renewable raw materials, easy treatment and resource utilization of waste residue, waste water and waste gas, and thus can be used in practice for the industrial production of vitamin B5, which is of significant application value.